Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Q Therapeutics, Inc. | Financial_Report.xls |
| EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER AND VICE PRESIDENT OF - Q Therapeutics, Inc. | ex32_2.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER AND VICE PRESIDENT OF - Q Therapeutics, Inc. | ex31_2.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER, DIRECTOR - Q Therapeutics, Inc. | ex31_1.htm |
| 10-K - ANNUAL REPORT - Q Therapeutics, Inc. | qholdings-10k_123111.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Q Holdings, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Deborah A. Eppstein, PhD, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: March 23, 2012
|
|
By: /s/ DEBORAH A. EPPSTEIN, PHD
|
|
|
|
Deborah A. Eppstein, Ph.D.
President and Chief Executive Officer, Director
(Principal Executive Officer) |